학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 350건 | 목록 1~20
Academic Journal
Terán E; Medical Oncology Department, Gastrointestinal Cancer Unit, Vall d'Hebron University Hospital, Barcelona, Spain. Electronic address: eduardoteran@vhio.net.; Pazo R; Medical Oncology Department, Miguel Servet University Hospital, Zaragoza, Spain.; Caritá L; Statistics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Alsina M; Medical Oncology Department, Hospital Universitario de Navarra (HUN), Navarrabiomed-IdiSNA, Pamplona, Spain.; Hierro C; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona, Badalona-Applied Group in Oncology (B-ARGO), Badalona, Barcelona, Spain.; Blanco C; Medical Oncology Department, Miguel Servet University Hospital, Zaragoza, Spain.; Reboredo M; Medical Oncology Department, A Coruña University Hospital, Galicia, Spain.; Landolfi S; Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Zucchiatti A; Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Visa L; Medical Oncology Department, Hospital del Mar Research Institute, Barcelona, Spain.; Calvo A; Medical Oncology Department, Gregorio Marañón University Hospital, Madrid, Spain.; López A; Medical Oncology Department, Burgos University Hospital, Burgos, Spain.; Vidal-Tocino R; Medical Oncology Department, C.A. Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Agra C; Medical Oncology Department, Hospital Universitario de Navarra (HUN), Navarrabiomed-IdiSNA, Pamplona, Spain.; Alés I; Medical Oncology Department, Málaga Regional University Hospital, Málaga, Spain.; Foti S; Medical Oncology Department, San Raffaele Scientific Institute, Milán, Italy.; García-Paredes B; Medical Oncology Department, Clínico San Carlos Hospital, Madrid, Spain.; Genovesi V; U.O Oncologia, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.; Fornaro L; U.O Oncologia, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.; Sauri T; Medical Oncology Department, Hospital Clínic de Barcelona, Barcelona, Spain; Translational Oncology in Upper Gastrointestinal Cancer Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Macías I; Medical Oncology Department, Hospital Clínic de Barcelona, Barcelona, Spain; Translational Oncology in Upper Gastrointestinal Cancer Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Martínez E; Medical Oncology Department, Marqués de Valdecilla University Hospital, Instituto de Investigación Valdecilla (IDIVAL), Santander, Spain.; Martínez J; Medical Oncology Department, Virgen de las Nieves University Hospital, Granada, Spain.; Buges C; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona, Badalona-Applied Group in Oncology (B-ARGO), Badalona, Barcelona, Spain.; Ribera P; Medical Oncology Department, Parc Taulí University Hospital, Badalona, Spain.; Herranz JM; Upper Gastrointestinal and Endocrine Tumor Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Acosta D; Medical Oncology Department, Gastrointestinal Cancer Unit, Vall d'Hebron University Hospital, Barcelona, Spain.; Vivancos A; Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Tabernero J; Medical Oncology Department, Gastrointestinal Cancer Unit, Vall d'Hebron University Hospital, Barcelona, Spain.; Élez E; Medical Oncology Department, Gastrointestinal Cancer Unit, Vall d'Hebron University Hospital, Barcelona, Spain.; Tian TV; Translational Oncology in Upper Gastrointestinal Cancer Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Upper Gastrointestinal and Endocrine Tumor Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: tiantian@vhio.net.; Macarulla T; Medical Oncology Department, Hospital Clínic de Barcelona, Barcelona, Spain; Translational Oncology in Upper Gastrointestinal Cancer Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Upper Gastrointestinal and Endocrine Tumor Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: macarulla@clinic.cat.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Academic Journal
Elez E; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.; Siena S; Università degli Studi di Milano, Niguarda Cancer Center and Department of Medical Oncology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Sartore-Bianchi A; Università degli Studi di Milano, Niguarda Cancer Center and Department of Medical Oncology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Ros J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.; Ciardello F; Università degli Studi della Campania 'Luigi Vanvitelli', Naples, Italy.; Martinelli E; Università degli Studi della Campania 'Luigi Vanvitelli', Naples, Italy.; Steeghs N; The Netherlands Cancer Institute, Amsterdam, The Netherlands; University Medical Center Utrecht, Utrecht, The Netherlands.; Huijberts S; KU Leuven, Leuven, Belgium; Amsterdam UMC, Amsterdam, The Netherlands.; Cervantes A; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Roselló S; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Tejpar S; UZ Gasthuisberg, Katholieke University Leuven, Leuven, Belgium; The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Wilmsen B; KU Leuven, Leuven, Belgium; Amsterdam UMC, Amsterdam, The Netherlands.; Salazar R; Catalan Institute of Oncology, Oncobell Program (IDIBELL), University of Barcelona (Campus Bellvitge), CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain.; Santos C; Catalan Institute of Oncology, Oncobell Program (IDIBELL), University of Barcelona (Campus Bellvitge), CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain.; de Schaetzen G; EORTC Headquarters, Brussels, Belgium.; Muñoz S; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.; Bernards R; UZ Gasthuisberg, Katholieke University Leuven, Leuven, Belgium; The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Moreno V; Catalan Institute of Oncology, Oncobell Program (IDIBELL), University of Barcelona (Campus Bellvitge), CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain; Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Department of Clinical Sciences, Faculty of Medicine and Health Sciences and University of Barcelona Institute of Complex Systems (UBICS), University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; García-Galera E; Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Alemany R; Catalan Institute of Oncology, Oncobell Program (IDIBELL), University of Barcelona (Campus Bellvitge), CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain.; Gros A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.; Bardelli A; Department of Oncology, University of Torino, Torino, Italy; IFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy.; Arena S; Department of Oncology, University of Torino, Torino, Italy; Candiolo Cancer Institute, FPO-IRCS, Candiolo, Torino, Italy.; Piris A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.; Chavarría E; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.; Dienstmann R; Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; University of Vic - Central University of Catalonia, Vic, Spain.; Tabernero J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain. Electronic address: jtabernero@vhio.net.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Academic Journal
Dienstmann R; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain. Electronic address: rdienstmann@vhio.net.; Vivancos A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Nuciforo P; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Aguilar S; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Ruiz-Pace F; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Viaplana C; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Gonzalez J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Fite B; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Pedrola A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Elez E; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Saura C; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Felip E; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Macarulla T; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Capdevila J; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Fariñas-Madrid L; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Carles J; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Muñoz-Cosuelo E; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Balmaña J; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Braña I; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Garralda E; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Tabernero J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain; IOB Institute of Oncology, Quiron Group (Quiron-IOB), Barcelona, Spain.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Academic Journal
Seguí E; SOLTI Cancer Research Group, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain; Medicine Department, University of Barcelona, Barcelona, Spain.; Brasó-Maristany F; SOLTI Cancer Research Group, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain; Medicine Department, University of Barcelona, Barcelona, Spain; Reveal Genomics, Barcelona, Spain.; Pascual T; SOLTI Cancer Research Group, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain; Medicine Department, University of Barcelona, Barcelona, Spain.; Sanfeliu E; SOLTI Cancer Research Group, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Pathology Department, Hospital Clinic of Barcelona, Barcelona, Spain.; Victoria I; Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain.; Saura C; SOLTI Cancer Research Group, Barcelona, Spain; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Hierro C; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona, Badalona-Applied Research Group in Oncology (B-ARGO), Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain.; López-González A; Complejo Asistencial Universitario de León, León, Spain.; Izarzugaza Y; Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.; Ciruelos E; SOLTI Cancer Research Group, Barcelona, Spain; Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain.; Gavilá J; SOLTI Cancer Research Group, Barcelona, Spain; Instituto Valenciano de Oncología (IVO), Valencia, Spain.; Racca F; IOB-Hospital Quironsalud Barcelona, Barcelona, Spain.; Cejalvo JM; SOLTI Cancer Research Group, Barcelona, Spain; Hospital Clínico Universitario de Valencia, INCLIVA (Instituto de Investigación Sanitaria), Universidad Valencia, Valencia, Spain.; Amillano K; Hospital Universitari Sant Joan de Reus, Reus, Spain.; Paz-Ares L; Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Instituto de Salud Carlos III, Madrid, Spain.; Juan M; Immunology Department, Immunotherapy Platforms, Hospital Clinic de Barcelona, Barcelona, Spain.; Felip E; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Garralda E; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; González B; SOLTI Cancer Research Group, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Reveal Genomics, Barcelona, Spain.; Arance A; Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain.; Martín-Liberal J; Catalan Institute of Oncology (ICO), Hospitalet, Barcelona, Spain.; Conte B; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medicine Department, University of Barcelona, Barcelona, Spain.; Walbaum B; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain; Medicine Department, University of Barcelona, Barcelona, Spain.; Indacochea A; Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain.; Castillo O; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Blasco P; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Pardo F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Reveal Genomics, Barcelona, Spain.; Aguirre Á; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Sirenko V; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; González X; SOLTI Cancer Research Group, Barcelona, Spain; Catalan Institute of Oncology (ICO), Hospitalet, Barcelona, Spain; Institut Oncològic Dr. Rosell, Hospital Universitari General de Catalunya, Sant Cugat del Vallès, Spain.; Galván P; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Vivancos A; Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Ferrero-Cafiero JM; SOLTI Cancer Research Group, Barcelona, Spain.; Mulero-Sánchez A; SOLTI Cancer Research Group, Barcelona, Spain.; Salvador F; SOLTI Cancer Research Group, Barcelona, Spain.; Villacampa G; SOLTI Cancer Research Group, Barcelona, Spain; Oncology Data Science, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Mesía R; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona, Badalona-Applied Research Group in Oncology (B-ARGO), Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain.; Cervantes A; Hospital Clínico Universitario de Valencia, INCLIVA (Instituto de Investigación Sanitaria), Universidad Valencia, Valencia, Spain; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Instituto de Salud Carlos III, Madrid, Spain.; Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain; Medicine Department, University of Barcelona, Barcelona, Spain; Reveal Genomics, Barcelona, Spain; IOB-Hospital Quironsalud Barcelona, Barcelona, Spain. Electronic address: alprat@clinic.cat.; Tabernero J; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; IOB-Hospital Quironsalud Barcelona, Barcelona, Spain; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Instituto de Salud Carlos III, Madrid, Spain; Medicine Department, University of Vic - Central University of Catalonia (UVic-UCC), Vic, Spain.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Academic Journal
Martelli V; Hospital del Mar Research Institute Barcelona, Medical Oncology Department, Hospital del Mar, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, Università degli Studi di Genova, Genoa, Italy.; Vidal J; Hospital del Mar Research Institute Barcelona, Medical Oncology Department, Hospital del Mar, Barcelona, Spain; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain.; Gibert J; Hospital del Mar Research Institute Barcelona, Pathology Department, Hospital del Mar, Barcelona, Spain.; Fernández-Rodríguez MC; Hospital del Mar Research Institute Barcelona, Pathology Department, Hospital del Mar, Barcelona, Spain.; Linares J; Hospital del Mar Research Institute Barcelona, Medical Oncology Department, Hospital del Mar, Barcelona, Spain; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain.; García-Alfonso P; Medical Oncology Department, Hospital Gregorio Marañón, Madrid, Spain.; Páez D; Medical Oncology Department, H. Santa Creu i Sant Pau, U705. CIBERER, Barcelona, Spain.; Alonso V; Medical Oncology Department, Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria de Aragón (IISA), Zaragoza, Spain.; Gomez-España MA; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain; Medical Oncology Department, IMIBIC, Reina Sofía Hospital, University of Cordoba, Córdoba, Spain.; Guix M; Hospital del Mar Research Institute Barcelona, Medical Oncology Department, Hospital del Mar, Barcelona, Spain; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain.; Santos C; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain; Medical Oncology Department, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL)-CIBERONC, Campus Bellvitge, University of Barcelona, Barcelona, Spain.; Duran G; Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spain.; Élez E; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Garcia-Carbonero R; Medical Oncology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12), UCM, Madrid, Spain.; Ferreiro R; Medical Oncology Department, Hospital Ramón y Cajal, Madrid, Spain.; Pineda E; Medical Oncology Department, Hospital Clínic, Barcelona, Spain.; Sastre J; Medical Oncology Department, Hospital Universitario Clínico San Carlos, IdISSC, Madrid, Spain.; Cano MT; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain; Medical Oncology Department, IMIBIC, Reina Sofía Hospital, University of Cordoba, Córdoba, Spain.; Manzano JL; Medical Oncology Department, ICO, H. Germans Trias i Pujol, Barcelona, Spain.; Losa F; Medical Oncology Department, Hospital Sant Joan Despí - Moisés Broggi, ICO-Hospitalet, Barcelona, Spain.; Aranda E; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain; Medical Oncology Department, IMIBIC, Reina Sofía Hospital, University of Cordoba, Córdoba, Spain.; Rivera F; Medical Oncology Department, Hospital Marques de Valdecilla, IDIVAL, Santander, Spain.; Sibilio A; Hospital del Mar Research Institute Barcelona, Medical Oncology Department, Hospital del Mar, Barcelona, Spain; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain.; Toledo R; Biomarker and Clonal Dynamic Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Tabernero J; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Salazar R; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain; Medical Oncology Department, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL)-CIBERONC, Campus Bellvitge, University of Barcelona, Barcelona, Spain.; Bellosillo B; Hospital del Mar Research Institute Barcelona, Pathology Department, Hospital del Mar, Barcelona, Spain.; Montagut C; Hospital del Mar Research Institute Barcelona, Medical Oncology Department, Hospital del Mar, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain. Electronic address: cmontagut@psmar.cat.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Academic Journal
de Grandis MC; Department of Oncology, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy.; Baraibar I; Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: ibaraibar@vhio.net.; Prior O; Radiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus (Spain), Barcelona, Spain.; Balaguer-Montero M; Radiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus (Spain), Barcelona, Spain.; Salvà F; Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Ros J; Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Rodríguez-Castells M; Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Tabernero J; Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Lonardi S; Department of Oncology, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy.; Perez-Lopez R; Radiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus (Spain), Barcelona, Spain; Radiology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Élez E; Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Conference
Annals of Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
Academic Journal
Stintzing S; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Hematology, Oncology and Cancer Immunology (CCM), Berlin, Germany. Electronic address: sebastian.stintzing@charite.de.; Tabernero J; Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology, Centro Cellex, Barcelona, Spain.; Satoh T; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.; Dasari A; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.; Lonardi S; Medical Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.; Eng C; Department of Medicine, Vanderbilt Ingram Cancer Center, Nashville, USA.; Garcia-Carbonero R; Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Elez E; Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology, Centro Cellex, Barcelona, Spain.; Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.; Sobrero AF; Department of Medical Oncology, Azienda Ospedaliera San Martino, Genoa, Italy.; Yao JC; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.; Kasper S; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; Arnold D; Department of Oncology and Hematology, Asklepios Tumorzentrum Hamburg, AK Altona, Hamburg, Germany.; Basic E; Department of Business and Economics, Berlin School of Economics and Law, Berlin, Germany.; Granold M; Takeda Pharma Vertrieb GmbH & Co. KG, Berlin, Germany.; Petschulies M; Takeda Pharma Vertrieb GmbH & Co. KG, Berlin, Germany.; Wu L; Takeda Development Center Americas, Inc. (TDCA), Lexington, USA.; Chung YC; Takeda Development Center Americas, Inc. (TDCA), Lexington, USA.; Chen L; Takeda Development Center Americas, Inc. (TDCA), Lexington, USA.; Yang Z; HUTCHMED International Inc., Florham Park, USA.; Van Cutsem E; Gastroenterology/Digestive Oncology, University Hospitals Gasthuisberg/Leuven & KULeuven, Leuven, Belgium.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] TABERNERO, J
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어